Molecular Modelling and Atomistic Insights into the Binding Mechanism of MmpL3 Mtb

Area of Science:

• Structural biology
• Drug discovery
• Mycobacterial research

Background:

• Mycobacterial membrane proteins Large (MmpLs) are essential for transporting various molecules and represent key therapeutic targets.
• The MmpL protein family, part of the resistance, nodulation, and division (RND) superfamily, is vital in mycobacteria.

Purpose of the Study:

• To model the three-dimensional structure of Mycobacterium tuberculosis MmpL3 using homology modeling.
• To identify potential binding sites and interactions of MmpL3 inhibitors.

Main Methods:

• Homology modeling using Modeller and SWISS-MODEL with M. smegmatis MmpL3 as a template.
• Molecular docking of MmpL3 inhibitors (BM212, NITD304, SPIRO, NITD349) and co-crystalized ligands (AU1235, ICA38, SQ109, rimonabant).
• Analysis of protein-ligand interactions via molecular dynamics simulations and Molecular Mechanics Poisson-Boltzmann surface area (MM/PBSA) calculations.

Main Results:

• Successful modeling of the M. tuberculosis MmpL3 structure.
• Identification of novel critical residues (Gln32, Leu165, Ile414, Phe35) involved in MmpL3 inhibitor binding.
• Insights into conformational changes of MmpL3 upon inhibitor interaction.

Conclusions:

• The study provides a structural basis for understanding MmpL3 function and inhibitor interactions.
• Identified residues offer potential sites for the design of novel anti-mycobacterial drugs targeting MmpL3.
• This research contributes to the development of new therapeutic strategies against tuberculosis.